I

Indiana Hemophilia and Thrombosis Center | Indianapolis, IN

Research site
(Unclaimed)
Location
8326 Naab Road, Indianapolis, Indiana, United States of America
Site insights

Top conditions

Hemophilia A (13 trials)

Von Willebrand Diseases (7 trials)

Hemophilia B (4 trials)

Thrombosis (4 trials)

Venous Thrombosis (3 trials)

Top treatments

Edoxaban
DDAVP
Voxelotor
AG-348
Pyruvate
Metformin
Efanesoctocog Alfa

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

4 of 29
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study of Recombinant Von Willebrand Factor (rVWF) in Pediatric and Adult Participants With Severe Von Willebrand Disease (VWD)

The main aim of the study is to check effectiveness of rVWF (vonicog alfa) prophylaxis based on the annualized bleeding rate (ABR) of spontaneous (no...

Enrolling
Von Willebrand Disease (VWD)
Biological: rVWF
Biological: rFVIII

The main aim of the study is to check effectiveness, side effects, and tolerability of recombinant von Willebrand Factor (rVWF), with or without ADVA...

Enrolling
Von Willebrand Disease
Biological: Antihemophilic Factor (Recombinant)
Biological: von Willebrand factor (Recombinant)

This study will evaluate the efficacy and safety of PF-06838435 (a gene therapy drug) in adult male participants with moderately severe to severe hem...

Active, not recruiting
Hemophilia B
Biological: PF-06838435/ fidanacogene elaparvovec

Open Label Extension Study of Voxelotor Clinical Trial Participants with Sickle Cell Disease Who Participated in Voxelotor Clinical Trials

Active, not recruiting
Sickle Cell Disease
Drug: Voxelotor

Trial sponsors

Baxalta logo

Baxalta (8 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems